Jump to content

DBL-583

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 16:52, 10 September 2016 (Updating {{infobox_drug}} (changes to verified and watched fields - updated 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'Verifiedfields') per Chem/infobox_drug validation (report [[Wikipedia talk:WikiProject_Pharmacology|err...). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

DBL-583
Identifiers
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC38H50F2N2O3
Molar mass620.826 g·mol−1
3D model (JSmol)
  • CCCCCCCCCC(=O)OC(CCN1CCN(CC1)CCOC(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)C4=CC=CC=C4
  • InChI=1S/C38H50F2N2O3/c1-2-3-4-5-6-7-11-14-37(43)45-36(31-12-9-8-10-13-31)23-24-41-25-27-42(28-26-41)29-30-44-38(32-15-19-34(39)20-16-32)33-17-21-35(40)22-18-33/h8-10,12-13,15-22,36,38H,2-7,11,14,23-30H2,1H3 ☒N
  • Key:IXQPQADYPIEKQC-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

DBL-583 is a selective dopamine reuptake inhibitor of the piperazine chemical class.[1] It is the decanoate ester of a hydroxy vanoxerine.[1] DBL-583 breaks down very slowly in the body, lasting for up to a month after a single injection.[1]

See also

References

  1. ^ a b c Baumann MH, Phillips JM, Ayestas MA, Ali SF, Rice KC, Rothman RB. Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence. Annals of the New York Academy of Sciences. 2002 Jun;965:92-108.



Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=DBL-583&oldid=738714964"